Shedding of active tissue factor by aortic smooth muscle cells (SMCs) undergoing apoptosis

Anne-Cécile Brisset1, Anne-Dominique Terrisse, Dominique Dupouy

  • 1Laboratoire d'Hématologie, Pavillon Caubet, Hôpital Purpan, 31059 Toulouse Cedex, France.

Thrombosis and Haemostasis
|September 6, 2003
PubMed

Insights

Apoptosis of synthetic smooth muscle cells (SMCs) in atherosclerotic plaques increases their procoagulant potential. Shed microparticles from dying SMCs promote thrombus formation, highlighting thrombotic risks in advanced atherosclerosis.

Area of Science:

  • Cardiovascular Biology
  • Thrombosis Research
  • Atherosclerosis Pathogenesis

Background:

  • Apoptosis of neo-intimal smooth muscle cells (SMCs) is characteristic of advanced atherosclerotic plaques.
  • SMCs in synthetic phenotype up-regulate Tissue Factor (TF) and Tissue Factor Inhibitor (TFPI), releasing significant TFPI.

Purpose of the Study:

  • To investigate the procoagulant properties of synthetic SMCs during apoptosis.
  • To determine the role of SMC-derived microparticles in thrombosis.

Main Methods:

  • Isolation of SMCs from rat aorta post-balloon injury.
  • Induction of apoptosis using Fas-ligand.
  • Measurement of surface TF activity, prothrombinase, and TFPI release.
  • Analysis of microparticle (MP) procoagulant function in vitro and in whole blood flow models.

Main Results:

  • Fas-ligand induced apoptosis in SMCs.
  • Surface TF activity increased 10-fold, with a proportional rise in prothrombinase, while membrane TF protein decreased.
  • Microparticles shed during SMC death carried functional TF, with unchanged TFPI release, shifting the balance towards a procoagulant state.
  • Shed MPs enhanced thrombus formation in flowing whole blood.

Conclusions:

  • Apoptotic SMCs in atherosclerotic plaques are a source of highly thrombogenic material.
  • Release of TF-bearing MPs during SMC death contributes to plaque thrombogenicity.
  • Plaque disruption can release this procoagulant material into circulation, increasing thrombotic risk.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.